Ftse Mib
36.147,88
0,25%
DAX
21.251,45
1,00%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
104.750,04
-1,34%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IceCure Medical Ltd (ICCM) IceCure Medical Ltd (ICCM) Notizie

IceCure Medical Ltd

ICCM
1,23
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:31:42
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/1/202513:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202513:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202513:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
06/1/202514:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202514:30PRNUSIceCure Medical Regains Full Nasdaq Compliance with Nasdaq..
03/1/202514:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202514:30PRNUSEuropean Patent Office Issues Intention to Grant Notice to..
30/12/202414:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202414:30PRNUSData on IceCure's ProSense® Cryoablation for Low-Risk Breast..
05/12/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/12/202414:30PRNUSIceCure's ProSense® Cryoablation Safe and Effective in..
26/11/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202414:30PRNUSIceCure Medical Reports 36% Sales Growth in the First Nine..
25/11/202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/11/202414:30PRNUSIceCure's Next-Generation Multiprobe Cryoablation Technology..
20/11/202414:30PRNUSIceCure Medical to Report Third Quarter 2024 Financial &..
19/11/202414:30PRNUSIceCure's ProSense® Chosen for Breast Cryoablation Study Led..
15/11/202403:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202416:05EDGAR2Form F-1/A - Registration statement for certain foreign..
08/11/202413:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202413:00PRNUSFDA Advisory Panel Votes in Favor of IceCure's ProSense®..
05/11/202422:41EDGAR2Form F-1/A - Registration statement for certain foreign..
29/10/202413:30PRNUSUpcoming FDA Advisory Panel for IceCure's ProSense®..
21/10/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/202414:30PRNUSIceCure Receives Notice of Allowance from U.S. Patent and..
15/10/202422:22EDGAR2Form F-1 - Registration statement for certain foreign..
07/10/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/10/202414:15PRNUSIceCure's ProSense® Featured in 6 Global Studies on..
24/9/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202414:15PRNUSIceCure's ICE3 5-Year Trial Results Published in the Peer..
16/9/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/9/202414:00PRNUSStudy Published in the British Journal of Radiology..
12/9/202414:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202414:00PRNUSIceCure Announces FDA Advisory Panel Meeting Date for..
04/9/202414:30PRNUSIceCure to Meet Institutional Investors at the H.C...
28/8/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202414:30PRNUSUSPTO Grants Notice of Allowance for Additional Patent on..
20/8/202415:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202414:30PRNUSIceCure Medical Reports 20% Growth in ProSense® System and..
16/8/202414:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202414:30PRNUSIceCure's ProSense® Destroyed 100% of Breast Cancer Tumors..
13/8/202414:30PRNUSIceCure Medical to Report Second Quarter 2024 Financial &..
07/8/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202414:30PRNUSIceCure Announces Positive Data from the Largest..
06/8/202422:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/7/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/7/202414:30PRNUS99.74% Recurrence Free Rate for Women with Breast Cancer..
19/7/202422:30PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
Apertura: Min: Max:
Chiusura: 1,23

La tua Cronologia

NASDAQ
ICCM
IceCure Medical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network